Richard Gregg serves as Executive at Vitae Pharmaceuticals, Inc, where they oversee executive responsibilities. Since joining the company, Richard Gregg has executed 10 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Oct 25, 2016 involved selling 228,274 shares valued at $4.8M.
Richard Gregg currently holds 228,274 shares of Vitae Pharmaceuticals, Inc (VTAE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Richard Gregg has been a net neutral trader of VTAE stock. They have purchased $0 and sold $0 worth of shares.
Richard Gregg's most recent insider trade was on Oct 25, 2016, when they sold 228,274 shares at $21.00 per share.
Get notified when new Form 4 filings are submitted
| 6,944 |
| $14.40 |
| Discretionary |
| Oct 19, 2016 | VTAE | $341.3K | Option Exercise | 87,301 | $3.91 | Discretionary |
| Oct 19, 2016 | VTAE | $211.5K | Option Exercise | 29,657 | $7.13 | Discretionary |
| Apr 29, 2016 | VTAE | $12.8K | Award | 2,100 | $6.11 | Discretionary |
| Nov 16, 2015 | VTAE | $58.6K | Option Exercise | 15,000 | $3.91 | Discretionary |
| Nov 16, 2015 | VTAE | $58.6K | Option Exercise | 15,000 | $3.91 | Discretionary |
| Nov 13, 2015 | VTAE | $53.5K | Option Exercise | 13,695 | $3.91 | Discretionary |
| Nov 13, 2015 | VTAE | $46.7K | Option Exercise | 6,773 | $6.90 | Discretionary |
| Nov 13, 2015 | VTAE | $254.5K | Option Exercise | 65,089 | $3.91 | Discretionary |